Cardiovascular Disease

AHA: Assessment and Promotion of Physical Activity for CVD Prevention

AHA: Assessment and Promotion of Physical Activity for CVD Prevention

By

The American Heart Association provided updated guidelines for the routine assessment of physical activity for healthcare systems and providers as a way to prevent future health complications.

Psoriasis Treatment Ixekizumab Safe for Cardiovascular Health

Psoriasis Treatment Ixekizumab Safe for Cardiovascular Health

Biologic therapies for psoriasis may have an impact on cardiovascular parameters, potentially resulting in the occurrence of major adverse cardiovascular events.

Cardiovascular Complications of COPD

Cardiovascular Complications of COPD

By

A 55-year-old man with chronic obstructive pulmonary disease reports having some mild chest pain.

AHA Examines CVD and Breast Cancer Relationship

AHA Examines CVD and Breast Cancer Relationship

By

The American Heart Association has released a scientific statement examining the relationship between cardiovascular disease and breast cancer.

Solid fuel use linked to increased cardiovascular and all-cause mortality

Solid fuel use for cooking and heating was associated with increased risk for cardiovascular and all-cause mortality.

Higher Mortality Risk Seen for 'Night Owls'

Higher Mortality Risk Seen for 'Night Owls'

Individuals with an evening preference had a higher risk for mortality and metabolic dysfunction.

Workplace Noise Exposure Affects Cardiovascular Risk Factors

Workplace Noise Exposure Affects Cardiovascular Risk Factors

High blood pressure, elevated cholesterol, and hearing problems were more common in workers exposed to loud noise.

Wildfire Smoke Exposure Tied to Higher CV, Cerebrovascular ER Visits

Wildfire Smoke Exposure Tied to Higher CV, Cerebrovascular ER Visits

There was an increased risk for all-cause cardiovascular and cerebrovascular emergency department visits, especially in individuals older than 65.

Declines Seen in Cardiovascular Risk Factors From 1990 to 2010

Declines Seen in Cardiovascular Risk Factors From 1990 to 2010

Despite the overall decreases in cardiovascular risk, metabolic risk, measured by obesity and hemoglobin A1c, increased over time.

Menopause Symptom Severity May Predict Heart Disease

Menopause Symptom Severity May Predict Heart Disease

By

Researchers examined whether menopausal symptoms, quality of life, and depression are related to arterial stiffness, a risk factor for cardiovascular disease.

Canagliflozin Reduces CV Death and Hospitalizations for Heart Failure in T2D

Canagliflozin Reduces CV Death and Hospitalizations for Heart Failure in T2D

By

Patients with type 2 diabetes at risk for heart failure are particularly likely to benefit from treatment with canagliflozin.

Informal CVD Caregiving Costs Estimated at $61 Billion in 2015

Informal CVD Caregiving Costs Estimated at $61 Billion in 2015

Costs related to informal caregiving for patients with cardiovascular disease may increase to $128 billion by 2035.

High Financial Burden for Families of Patients With ASCVD

High Financial Burden for Families of Patients With ASCVD

High burden of expenses were seen for 1 in 4 low-income families with a member with atherosclerotic cardiovascular disease.

Adults More Inclined to Take Tea, Pill for Hypertension

Adults More Inclined to Take Tea, Pill for Hypertension

Preferences indicated people would rather take daily pill or tea to prolong life rather than exercise.

Eating Pecans May Cut Risk for Cardiovascular Disease, Diabetes

Eating Pecans May Cut Risk for Cardiovascular Disease, Diabetes

Benefits were seen in markers of cardiometabolic disease, including insulin sensitivity, from a pecan-rich diet.

Antidiabetic Drugs and Cardiovascular Risk: Expert Perspectives

Antidiabetic Drugs and Cardiovascular Risk: Expert Perspectives

By

Although many of the newer antidiabetic drugs have demonstrated favorable outcomes in clinical trials, some have also been associated with increased risk of adverse CV outcomes.

HbA1c Levels Affect Serum Phospholipids, Inflammation in T2D, CVD

HbA1c Levels Affect Serum Phospholipids, Inflammation in T2D, CVD

By

Investigators sought to determine the association between serum phospholipid fatty acid composition, low-grade inflammation, and glycemic control in patients with T2D.

Low Sperm Count Associated With Worse Metabolic, Cardiovascular, and Bone Health

Low Sperm Count Associated With Worse Metabolic, Cardiovascular, and Bone Health

By

Researchers tested whether semen quality and reproductive function could be a marker of general health in men.

Cardiovascular Health Declining in the United States

Cardiovascular Health Declining in the United States

Decrease in disparities between race/ethnicity due to worsening CV health among whites 1988-2014.

Tresiba Label Updated With Data on Cardiovascular Outcomes

Tresiba Label Updated With Data on Cardiovascular Outcomes

By

The FDA has approved an update to the prescribing information for Tresiba to include cardiovascular outcomes and severe hypoglycemia study data.

Assessing CVD Risk With BMI Susceptible to Confounding

Assessing CVD Risk With BMI Susceptible to Confounding

Low body mass index correlated with higher incidence of cardiovascular disease; the lowest risk was seen at a body mass index of 22 to 23 kg/m2.

Cardiovascular Disease Mortality Risk With Lead Exposure

Cardiovascular Disease Mortality Risk With Lead Exposure

Exposure to lead may increase the risk for all-cause, cardiovascular, and ischemic heart disease mortality.

Cardiovascular Outcomes of SGLT-2i vs Other Glucose-Lowering Drugs in T2D

Cardiovascular Outcomes of SGLT-2i vs Other Glucose-Lowering Drugs in T2D

By

A recent study evaluated the effects of SGLT-2i and other glucose-lowering drugs on cardiovascular event outcomes in patients with type 2 diabetes from 6 countries in 3 world regions.

Febuxostat May Increase CV Mortality Compared With Allopurinol in Gout

Febuxostat May Increase CV Mortality Compared With Allopurinol in Gout

Patients with gout and cardiovascular disease who were treated with febuxostat had significantly higher all-cause and cardiovascular mortality compared with those treated with allopurinol.

Cardiovascular Disease Mortality, Morbidity Linked to Obesity

Cardiovascular Disease Mortality, Morbidity Linked to Obesity

Obesity is associated with increased morbidity and mortality related to cardiovascular disease, compared with normal body mass index.

Prognosis for Prediabetes Worse Depending on Defining Measurement

Prognosis for Prediabetes Worse Depending on Defining Measurement

The prognosis was worse for prediabetes when defined by hemoglobin A1c than when defined by fasting plasma glucose.

Age at Type 2 Diabetes Diagnosis May Affect Mortality Risk

Age at Type 2 Diabetes Diagnosis May Affect Mortality Risk

Patients who are diagnosed for type 2 diabetes at a younger age may have an increased risk for mortality.

Cardiorespiratory Fitness May Improve Executive Function in Mild Cognitive Impairment

Cardiorespiratory Fitness May Improve Executive Function in Mild Cognitive Impairment

Investigators sought to determine the association between cardiorespiratory fitness by maximal oxygen uptake with white matter fiber integrity and neurocognitive performance.

Cardiovascular Risk Predictors in Cancer Survivors

Cardiovascular Risk Predictors in Cancer Survivors

A history of cancer was associated with higher fibrinogen concentration, von Willebrand factor, and antithrombin activity, independent of cardiovascular risk factors.

Beyond a Respiratory Disease: Cardiovascular Complications of Pneumonia

Beyond a Respiratory Disease: Cardiovascular Complications of Pneumonia

By

Pre-existing cardiovascular disease is the strongest risk factor for cardiovascular complications in patients with pneumonia.

Sign Up for Free e-Newsletters